Compare SNN & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SNN | PEN |
|---|---|---|
| Founded | 1856 | 2004 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.3B | 12.9B |
| IPO Year | N/A | 2015 |
| Metric | SNN | PEN |
|---|---|---|
| Price | $33.40 | $329.48 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 17 |
| Target Price | $36.25 | ★ $357.33 |
| AVG Volume (30 Days) | ★ 659.5K | 543.5K |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | ★ 2.27% | N/A |
| EPS Growth | N/A | ★ 1155.56 |
| EPS | N/A | ★ 4.52 |
| Revenue | N/A | ★ $1,403,665,000.00 |
| Revenue This Year | $8.61 | $14.34 |
| Revenue Next Year | $5.60 | $13.71 |
| P/E Ratio | ★ $64.97 | $72.88 |
| Revenue Growth | N/A | ★ 17.50 |
| 52 Week Low | $25.45 | $221.26 |
| 52 Week High | $38.79 | $362.41 |
| Indicator | SNN | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 54.49 | 37.63 |
| Support Level | $32.03 | $326.58 |
| Resistance Level | $33.89 | $338.99 |
| Average True Range (ATR) | 0.54 | 2.24 |
| MACD | 0.23 | -0.22 |
| Stochastic Oscillator | 84.76 | 26.14 |
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.